Neurosense Therapeutics (NRSN) traded up 0.82 % during a 24 hours period ending at 03:34 PM Central Europe on Monday 26th. One Neurosense Therapeutics stock can currently be bought for about USD 2.46 on popular exchanges. Current supply of Neurosense Therapeutics stocks is 1.9 mn. Neurosense Therapeutics has a current market capitalization of USD 4.7 mn and approximately USD 27.6 k worth of Neurosense Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Neurosense Therapeutics has traded -66.76 % down. Simple moving average of last 200 days is at USD 13.33. The highest price of past 52 weeks was recorded at USD 25.4 on 11/19/2025. 52 weeks low was at USD 2.15 on 10/22/2026.
Here is how related stocks have performed in the past 24 hours:
Tat (TATT.TA) traded down -1.48 % and now trades at ILA 32.27. Current market capitalisation for Tat is ILA 1.3 bn. Tat has a current price to earnings ratio of 20.33.
Maris - Tech (MTEK) traded up 8.72 % and now trades at USD 0.41. Maris - Tech has a market capitalisation of USD 4.5 mn.
Brainsway (BWAY.TA) traded down -4.63 % and now trades at ILA 3,427. Current market capitalisation for Brainsway is ILA 446.5 mn. Current price/earnings ratio for Brainsway is 48.5.
Icecure Medical (ICCM) traded up 1 % and now trades at USD 1.01. Icecure Medical has a market capitalisation of USD 4.7 mn.
Wearable Devices (WLDS) traded down -3.6 % and now trades at USD 1.39. Wearable Devices has a market capitalisation of USD 4.3 mn.
About Neurosense Therapeutics
NeuroSense Therapeutics Ltd is a clinical stage drug development company that specializes in treating ALS patients and other neurodegenerative diseases. The company operates globally, serving patients worldwide. You can find more information about their mission and offerings on their website, www.neurosense-tx.com , and they are traded on the Nasdaq stock exchange.
